Over the last six months, Brookdale’s shares have sunk to $5.81, producing a disappointing 15.9% loss - a stark contrast to the S&P 500’s 5.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Is there a buying opportunity in Brookdale, or does it present a risk to your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free.
Despite the more favorable entry price, we don't have much confidence in Brookdale. Here are three reasons why BKD doesn't excite us and a stock we'd rather own.
Founded in 1978, Brookdale Senior Living (NYSE:BKD) offers independent living, assisted living, Alzheimer's and dementia care, rehabilitation, and skilled nursing care.
Examining a company’s long-term performance can provide clues about its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Brookdale struggled to consistently generate demand over the last five years as its sales dropped at a 5.1% annual rate. This wasn’t a great result and is a sign of poor business quality.
Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.
Brookdale’s earnings losses deepened over the last five years as its EPS dropped 4.1% annually. We tend to steer our readers away from companies with falling EPS, where diminishing earnings could imply changing secular trends and preferences. If the tide turns unexpectedly, Brookdale’s low margin of safety could leave its stock price susceptible to large downswings.
As long-term investors, the risk we care about most is the permanent loss of capital, which can happen when a company goes bankrupt or raises money from a disadvantaged position. This is separate from short-term stock price volatility, something we are much less bothered by.
Brookdale burned through $35.07 million of cash over the last year, and its $5.65 billion of debt exceeds the $328.8 million of cash on its balance sheet. This is a deal breaker for us because indebted loss-making companies spell trouble.
Unless the Brookdale’s fundamentals change quickly, it might find itself in a position where it must raise capital from investors to continue operating. Whether that would be favorable is unclear because dilution is a headwind for shareholder returns.
We remain cautious of Brookdale until it generates consistent free cash flow or any of its announced financing plans materialize on its balance sheet.
We see the value of companies helping consumers, but in the case of Brookdale, we’re out. Following the recent decline, the stock trades at 3.1× forward EV-to-EBITDA (or $5.81 per share). While this valuation is optically cheap, the potential downside is huge given its shaky fundamentals. There are better stocks to buy right now. Let us point you toward a dominant Aerospace business that has perfected its M&A strategy.
The Trump trade may have passed, but rates are still dropping and inflation is still cooling. Opportunities are ripe for those ready to act - and we’re here to help you pick them.
Get started by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.
Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。